 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Research > Harvard Bioscience, Inc.
 |
Harvard Bioscience, Inc. |
 |
 |
 |
PROFILE |
 |
With some 10,000 products on its roster, Harvard Bioscience makes tools that aid in the drug-development process. One focus is protein purification. Another focus is ADMET (absorption, distribution, metabolism, elimination, and toxicology): It sells tests to screen drug candidates for these qualities. Subsidiary Biochrom makes instruments such as spectrophotometers, amino acid analyzers, and protein calculators. The firm sells its products directly in Canada, France, Germany, the UK, and the US, and through distributors elsewhere around the world. APBiotech has a distribution deal with the firm and accounts for almost 40% of its sales. Christopher Dick controls 25% of the firm; CEO Chane Graziano owns nearly 20%.
COMPETITION |
 |
Applied Biosystems Group (ABI)
Becton, Dickinson and Company (BDX)
Bio-Rad Laboratories, Inc. (BIO)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 30.60
1-Yr. Sales Growth: 16.8%
Employees: 139
Revenue per employee: $220,143.88
KEY PEOPLE |
 |
Chane Graziano
CEO
James L. Warren
CFO
CONTACT INFO |
 |
84 October Hill Rd.
Holliston, MA 01746
US
Phone: 508-893-8999
Fax: 508-429-5732
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |